1-5 of 5
Jan Eucker
Close
Sort by
Journal Articles

Treatment of Bortezomib Increases Osteoblast Function in Patients with Multiple Myeloma.

Ulrike Heider, MD, Martin Kaiser, MD, Christian Müller, MD, Carsten-Oliver Schulz, MD, Christian Jakob, MD, Ivana Zavrski, MD, Jan Eucker, MD, Jan Sterz, MD, Lorenz Kleeberg, MD, Kurt Possinger, MD, Orhan Sezer, MD
Journal: Blood
Blood (2005) 106 (11): 3457.
https://doi.org/10.1182/blood.V106.11.3457.3457
Published: 2005
Journal Articles

Serum Total-RANKL Is Elevated in Patients with Multiple Myeloma, Increases with ISS Stage and Decreases after Induction Therapy.

Christian Jakob, MD, Jan Sterz, MD, Lorenz Kleeberg, MD, Ivana Zavrski, MD, Martin Kaiser, MD, Jan Eucker, MD, Ulrike Heider, MD, Kurt Possinger, MD, Orhan Sezer, MD
Journal: Blood
Blood (2005) 106 (11): 2511.
https://doi.org/10.1182/blood.V106.11.2511.2511
Published: 2005
Journal Articles

Induction of Apoptosis in Multiple Myeloma by Ligands of Peroxisome Proliferator-Activated Receptor γ (PPAR-γ).

Jan Eucker, MD, Katharina Baengeroth, Ivana Zavrski, MD, Holger Krebbel, Chuanbing Zang, PhD, Ulrike Heider, MD, Christian Jakob, MD, Elena Elstner, PhD, Kurt Possinger, MD, Orhan Sezer, MD
Journal: Blood
Blood (2004) 104 (11): 4848.
https://doi.org/10.1182/blood.V104.11.4848.4848
Published: 2004
Journal Articles

Circulating Proteasome Level Is an Independent Prognostic Factor for Survival in Patients with Multiple Myeloma.

Christian Jakob, MD, Karl Egerer, PhD, Eugen Feist, MD, Ivana Zavrski, MD, Jan Eucker, MD, Ulrike Heider, MD, Gerd Burmester, MD, Kurt Possinger, MD, Peter M. Kloetzel, PhD, Orhan Sezer, MD
Journal: Blood
Blood (2004) 104 (11): 1486.
https://doi.org/10.1182/blood.V104.11.1486.1486
Published: 2004
Journal Articles

Immunocytochemistry reveals RANKL expression of myeloma cells

Orhan Sezer, Ulrike Heider, Christian Jakob, Ivana Zavrski, Jan Eucker, Kurt Possinger, Christine Sers, Veit Krenn
Journal: Blood
Blood (2002) 99 (12): 4646–4647.
https://doi.org/10.1182/blood-2002-01-0148
Published: 2002